Showing 1 - 10 of 100
Persistent link: https://www.econbiz.de/10013342443
Persistent link: https://www.econbiz.de/10013342444
Persistent link: https://www.econbiz.de/10003542001
We construct and test a new model of employer-provided health insurance provision in the presence of adverse selection in the health insurance market. In our model, employers cannot observe the health of their employees, but can decide whether to offer insurance. Employees sort themselves among...
Persistent link: https://www.econbiz.de/10012466234
We examine the evolving structure of the U.S. hospital industry since 1970, focusing on how ownership form influences entry and exit behavior. We develop theoretical predictions based on the model of Lakdawalla and Philipson, in which for-profit and not-for-profit hospitals differ regarding...
Persistent link: https://www.econbiz.de/10009441040
The nature and normative properties of competition in health care markets have long been the subject of debate. In this paper we consider what the optimal benchmark is in the presence of moral hazard effects on consumption due to health insurance. Moral hazard is widely recognized as one of the...
Persistent link: https://www.econbiz.de/10009441045
We examine the evolving structure of the U.S. hospital industry since 1970, focusing on how ownership form influences entry and exit behavior. We develop theoretical predictions based on the model of Lakdawalla and Philipson, in which for-profit and not-for-profit hospitals differ regarding...
Persistent link: https://www.econbiz.de/10009441241
There has been considerable consolidation in the hospital industry in recent years. Over 900 deals occurred from 1994-2000, and many local markets, even in large urban areas, have been reduced to monopolies, duopolies, or triopolies. This surge in consolidation has led to concern about...
Persistent link: https://www.econbiz.de/10009441255
Persistent link: https://www.econbiz.de/10013342445
Recently, many US employers have adopted less generous prescription drug benefits. In addition, the U.S. began to offer prescription drug insurance to approximately 42 million Medicare beneficiaries in 2006. We use data on individual health insurance claims and benefit data from 1997-2003 to...
Persistent link: https://www.econbiz.de/10005135264